The application of cancer stem cell model in malignant mesothelioma

被引：4
作者：
Bronte, Giuseppe [1 ,4 ]
Procopio, Antonio Domenico [1 ,2 ]
Graciotti, Laura [3 ]
机构：
[1] Univ Politecn Marche, Dept Clin & Mol Sci DISCLIMO, Ancona, Italy
[2] Natl Inst Hlth & Sci Ageing INRCA IRCCS, Clin Lab & Precis Med, Ancona, Italy
[3] Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy
[4] Univ Politecn Marche, Dept Clin & Mol Sci DISCLIMO, Via Tronto 10-A, Ancona, Italy
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2022年 / 174卷
关键词：
Malignant mesothelioma; Cancer stem cells; Chemoresistance; PLEURAL MESOTHELIOMA; IDENTIFICATION; RESISTANCE; MUTATIONS; CISPLATIN; ASBESTOS; THERAPY; MARKERS; TARGET; BAP1;
D O I：
10.1016/j.critrevonc.2022.103698
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The high mortality rate of malignant pleural mesothelioma led to study the mechanisms for chemoresistance. The cancer stem cell (CSC) model has been proposed to explain chemoresistance. CSCs are characterized by self-renewal capacity, that is detected through tumor-initiating cell assays. As in other malignancies, many studies sought to identify surface markers to isolate CSCs from malignant mesothelioma. Other studies characterized malignant mesothelioma CSCs for the expression of specific genes involved in stemness and the expression of proteins involved in chemoresistance. However, the main methods to characterize isolated CSCs include sphere formation, invasiveness, tumor-initiating capacity and expression of specific surface markers. The better knowledge of malignant mesothelioma CSCs allowed exploring new potential targets to develop specific treatments.
引用
收藏
页数：7
相关论文
共 53 条
[1]  
Adhikary Gautam, 2018, Oncotarget, V9, P34495, DOI 10.18632/oncotarget.26130
[2]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[3]   First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial [J].
Baas, Paul ;
Scherpereel, Arnaud ;
Nowak, Anna K. ;
Fujimoto, Nobukazu ;
Peters, Solange ;
Tsao, Anne S. ;
Mansfield, Aaron S. ;
Popat, Sanjay ;
Jahan, Thierry ;
Antonia, Scott ;
Oulkhouir, Youssef ;
Bautista, Yolanda ;
Cornelissen, Robin ;
Greillier, Laurent ;
Grossi, Francesco ;
Kowalski, Dariusz ;
Rodriguez-Cid, Jeronimo ;
Aanur, Praveen ;
Oukessou, Abderrahim ;
Baudelet, Christine ;
Zalcman, Gerard .
LANCET, 2021, 397 (10272) :375-386
[4]   Environmental risk of mesothelioma in the United States: An emerging concern-epidemiological issues [J].
Baumann, Francine ;
Carbone, Michele .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2016, 19 (5-6) :231-249
[5]   Asbestos is not just asbestos: an unrecognised health hazard [J].
Baumann, Francine ;
Ambrosi, Jean-Paul ;
Carbone, Michele .
LANCET ONCOLOGY, 2013, 14 (07) :576-578
[6]   Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells [J].
Blum, Walter ;
Pecze, Laszlo ;
Felley-Bosco, Emanuela ;
Wu, Licun ;
de Perrot, Marc ;
Schwaller, Beat .
STEM CELL REPORTS, 2017, 8 (04) :1005-1017
[7]   The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? [J].
Bronte, Giuseppe ;
Incorvaia, Lorena ;
Rizzo, Sergio ;
Passiglia, Francesco ;
Galvano, Antonio ;
Rizzo, Fabio ;
Rolfo, Christian ;
Fanale, Daniele ;
Listi, Angela ;
Natoli, Clara ;
Bazan, Viviana ;
Russo, Antonio .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 107 :20-32
[8]   Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations [J].
Bueno, Raphael ;
Stawiski, Eric W. ;
Goldstein, Leonard D. ;
Durinck, Steffen ;
De Rienzo, Assunta ;
Modrusan, Zora ;
Gnad, Florian ;
Nguyen, Thong T. ;
Jaiswal, Bijay S. ;
Chirieac, Lucian R. ;
Sciaranghella, Daniele ;
Dao, Nhien ;
Gustafson, Corinne E. ;
Munir, Kiara J. ;
Hackney, Jason A. ;
Chaudhuri, Amitabha ;
Gupta, Ravi ;
Guillory, Joseph ;
Toy, Karen ;
Ha, Connie ;
Chen, Ying-Jiun ;
Stinson, Jeremy ;
Chaudhuri, Subhra ;
Zhang, Na ;
Wu, Thomas D. ;
Sugarbaker, David J. ;
de Sauvage, Frederic J. ;
Richards, William G. ;
Seshagiri, Somasekar .
NATURE GENETICS, 2016, 48 (04) :407-+
[9]   SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells [J].
Canino, C. ;
Mori, F. ;
Cambria, A. ;
Diamantini, A. ;
Germoni, S. ;
Alessandrini, G. ;
Borsellino, G. ;
Galati, R. ;
Battistini, L. ;
Blandino, R. ;
Facciolo, F. ;
Citro, G. ;
Strano, S. ;
Muti, P. ;
Blandino, G. ;
Cioce, M. .
ONCOGENE, 2012, 31 (26) :3148-3163
[10]   SV40 and human mesothelioma [J].
Carbone, Michele ;
Gazdar, Adi ;
Butel, Janet S. .
TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 :S47-S59
123456